View More Recent Stories

Dec 8, 2020 07:00AM PharmaTher Files FDA Pre-IND Meeting Request for Ketamine in Parkinson’s Disease
Dec 1, 2020 07:00AM PharmaTher Expands Research Partnership with University Health Network For Development of Digital Therapeutics Platform
Nov 24, 2020 11:09AM PharmaTher Provides Update on its Psychedelic Pharmaceuticals Programs
Nov 18, 2020 07:00AM Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics
Nov 18, 2020 07:00AM PharmaTher Enters Into Research Collaboration with Revive Therapeutics for Psilocybin and panaceAI™ Psychedelic Discovery AI Platform
Nov 16, 2020 07:00AM PharmaTher Expands Patent Portfolio with Filing of U.S. Patent for Novel Use of Psilocybin to Treat Cancer
Nov 11, 2020 07:00AM Prolific Parkinson’s Researcher Dr. Alberto J. Espay Joins Pharmather as Scientific Advisor
Oct 29, 2020 07:00AM Leading Parkinson’s Researcher Dr. Robert A. Hauser Joins Pharmather as Scientific Advisor
Oct 27, 2020 07:00AM Pharmather Files for FDA Orphan Drug Designation for Ketamine in Neuropathic Pain
Oct 22, 2020 07:00AM Pharmather Secures Exclusive Rights to Novel Microneedle Delivery Technology for Psychedelic Pharmaceuticals
Oct 20, 2020 07:00AM Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson's Disease
View More Recent Stories